Renaissance Technologies’s Burning Rock Biotech BNR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$571K Buy
35,407
+4,290
+14% +$112K ﹤0.01% 2549
2025
Q4
$627K Sell
31,117
-600
-2% -$8.76K ﹤0.01% 2485
2025
Q3
$274K Hold
31,717
﹤0.01% 3037
2025
Q2
$100K Hold
31,717
﹤0.01% 3298
2025
Q1
$143K Sell
31,717
-600
-2% -$3.75K ﹤0.01% 3138
2024
Q4
$218K Sell
32,317
-600
-2% -$2.76K ﹤0.01% 3141
2024
Q3
$107K Sell
32,917
-700
-2% -$3.86K ﹤0.01% 3246
2024
Q2
$217K Sell
33,617
-653
-2% -$4.97K ﹤0.01% 3020
2024
Q1
$250K Sell
34,270
-260
-0.8% -$2.17K ﹤0.01% 3154
2023
Q4
$321K Sell
34,530
-670
-2% -$6.16K ﹤0.01% 2958
2023
Q3
$341K Sell
35,200
-410
-1% -$6.4K ﹤0.01% 2873
2023
Q2
$766K Sell
35,610
-680
-2% -$18K ﹤0.01% 2633
2023
Q1
$1.02M Sell
36,290
-1,660
-4% -$49.7K ﹤0.01% 2470
2022
Q4
$854K Sell
37,950
-16,130
-30% -$368K ﹤0.01% 2624
2022
Q3
$1.29M Sell
54,080
-55,740
-51% -$1.8M ﹤0.01% 2339
2022
Q2
$3.2M Buy
109,820
+98,460
+867% +$4.4M ﹤0.01% 1868
2022
Q1
$1.05M Sell
11,360
-5,179
-31% -$450K ﹤0.01% 2690
2021
Q4
$1.58M Buy
16,539
+15,529
+1,538% +$2.13M ﹤0.01% 2340
2021
Q3
$181K Buy
+1,010
New +$225K ﹤0.01% 3226

Other funds holding BNR

Renaissance Technologies's BNR Position: Q1 2026 in Review

Renaissance Technologies increased its Burning Rock Biotech (BNR) stake by 14% in Q1 2026, buying an estimated $112K and bringing the position to 35,407 shares worth $571K. The position accounts for ﹤0.01% of the portfolio, ranked #2549.

Renaissance Technologies first reported a position in BNR in Q3 2021 and has held it in 19 quarters since. The position peaked at $3.2M in Q2 2022. 16 funds tracked by Wall St. Rank hold BNR as of Q1 2026.

  • Renaissance Technologies held 35,407 shares of Burning Rock Biotech worth $571K as of Q1 2026.
  • Renaissance Technologies bought 4,290 Burning Rock Biotech shares in Q1 2026, an estimated $112K.
  • Burning Rock Biotech made up ﹤0.01% of Renaissance Technologies's portfolio in Q1 2026, its #2549 holding.
  • Renaissance Technologies first reported a position in Burning Rock Biotech in Q3 2021 and has held it in 19 quarters since.
  • Renaissance Technologies's Burning Rock Biotech position peaked at $3.2M in Q2 2022.
  • 16 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.